F5
Coagulation factor V
As of the edition of 20 October 2026, F5 (coagulation factor V, UniProt P12259) has 1 drug tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P12259
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- Secreted
- Solved structures
- 23
- Disease areas
- Infections; Lungs and airways; Heart and blood vessels; Blood and lymph; Cancer; Digestive system; Nervous system; Pregnancy and women's health
- Registered trials of its drugs
- 19
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Drotrecogin alfa (activated) | Marketed | Phase 4 | Ended 2013 |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |